| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 01:18 | Mike Kelly invests in Colorado St Hlth Facs Auth Rev R | ||
| 01:18 | Sara Jacobs from California's 51st district sells Qualcomm shares worth up to $2 million | ||
| 01:18 | Daniel Meuser from Pennsylvania's 9th district partially sells NVIDIA Corporation stock | ||
| 00:18 | Biogen, Denali discontinue Parkinson's drug after trial fails | ||
| 00:06 | Halliburton declares $0.17 quarterly dividend | ||
| 00:06 | Zentalis to present ovarian cancer trial data at ASCO meeting | ||
| 00:06 | Conduent to sell public transit unit to Modaxo for $164 million | ||
| 00:06 | Four Corners Property Trust buys North Carolina property | ||
| Do | Lockheed Martin breaks ground on Alabama munitions facility | ||
| Do | Crescent Biopharma to present CR-001 trial data at ASCO meeting | ||
| Do | Manulife announces executive leadership changes | ||
| Do | Black Diamond reports silevertinib trial results in lung cancer | ||
| Do | Equus Total Return reports net asset value rise to $1.50 | ||
| Do | Bernstein initiates Neurocrine stock with outperform rating on drug potential | ||
| Do | Bernstein initiates Revolution stock coverage at Market Perform on valuation | ||
| Do | Bernstein initiates BioNTech stock coverage citing pipeline concerns | ||
| Do | Bernstein initiates Incyte stock coverage with concerns on growth | ||
| Do | Bernstein initiates Jazz Pharmaceuticals stock with market perform | ||
| Do | Bernstein downgrades Summit Therapeutics stock rating on trial concerns | ||
| Do | Bernstein initiates Nuvalent stock coverage with outperform rating | ||
| Do | Moleculin presents cardiac safety data for Annamycin at ASCO | ||
| Do | Regeneron reports positive trial results for amyloidosis treatment | ||
| Do | Lilly to present oncology data at 2026 ASCO meeting | ||
| Do | Natera to present 35 oncology abstracts at ASCO meeting | ||
| Do | Whitehawk expands ADC pipeline with Hangzhou DAC option deal |